SlideShare a Scribd company logo
1 of 11
Antigens & Haptens
Name - Kajal Sharma
Course – B. Pharm (8th sem)
College – K.R. Mangalam University
Antigens
• Antigen is defined as ‘a macromolecular entity that
essentially elicits an immune response via the formation
of specific antibodies in the body of the host’.
• They are the substances that are capable of inducing
specific immune response.
• They can be recognized by the surface antibody(B cells)
or by the T cell receptors when associated with MHC
(Major histocompatibility complex) molecule.
• They can bind specifically with the antibody or T- cell
receptor.
MOST IMPORTANTLY
All immunogen are antigen but all antigen are not immunogen
(An immunogen is any antigen that is capable of inducing humoral and/or cell-mediated immune response)
Classification of Antigens
• EXOGENOUS ANTIGENS : Exogenous antigens are
those antigens which enter into the host body from their
surroundings or external environments. These are
basically of pollutants, microorganisms, pollens, drugs
etc.
• ENDOGENOUS ANTIGENS : They are again classified
onto-
• Xenogenic or Heterogenic antigens
• Allogenic or Idiotypic antigens
• Autologous antigens.
• XENOGENIC ANTIGENS : Foreign items which are related
with tissue transplantation and serology.
• ALLOGENIC ANTIGENS : Foreign items which enter when
an individual receives a blood transfusion or undergoes
transplantation operation.
• AUTOLOGOUS ANTIGENS : This group of antigens is very
rare and unnatural. In normal condition, self-components are
non-immunogenic in nature, but in an abnormal condition self-
body components are started to be considered as non-self or
antigenic component.
Immunogenicity v/s Antigenicity
• IMMUNOGENICITY : Ability to induce a humoral or
cell mediated immune response.
• ANTIGENICITY : Ability to combine specifically with
the final products of humoral or cell mediated immune
response.
• All molecules possessing the property of immunogenicity
also possess the property of antigenicity.
• Some molecules that possess the property of antigenicity
but lack immunogenicity is known as haptens.
Factors that influence
Immunogenicity
1. Contribution of the Immunogen
• Foreignness
• Molecular size
• Chemical Composition
• Physical Form
• Degradability
2. Contribution of the biological system
• Genetic factors
• Age
3. Method of administration
• Dose
• Route
• Adjuvants
Haptens
• Haptens are low molecular weight compound or molecules.
• Small organic molecules that are antigenic but not
immunogenic.
• They can bind to antibodies by themselves but they are not
recognised by the immune cells.
• And hence they fail to induce immune response, as a result no
antibodies to act against hapten.
• WHY HAPTENS ARE NOT IMMUNOGEN ?
• Haptens cannot bind to MHC/MHC-II (Major
histocompatibility complex). Hence cannot bind to TCR (T-
cell receptor).
• Results in no immune response
• Haptens can be immunogenic if they are covalently coupled
with a carrier protein.
• The carrier protein must be a larger protein having a molecular
weight of above 10,000 Da.
• This hapten-carrier conjugate is recognized by immune cells
and processed and presented to T-cell by MHC-II.
• Hence antibodies are generated. When hapten carrier conjugate
is introduced in body antibodies are generated against hapten,
carrier protein or conjugate.
Examples of Haptens
• Urushiol from the plant poison ivy.
• Hydralazine (generates autoimmune disease, Lupus
erythematosus).
• Nickel ion (ACD-allergic contact dermatitis).
• Halothane (cause hepatitis).
• Penicillin ( hemolytic anemia).
Tests
Test for Antigen :
i. Direct ELISA
ii. Direct Immunofluorescence
iii. RIA ( Radioimmunoassay technique)
iv. Neutralization test
v. CFT (Complement fixation test)
vi. Immunohistochemistry
vii. rapid antigen test (RAT)
Test for Hapten :
i. Patch Test procedure
References
1. Sambamurthy K, Kar Ashutosh. Pharmaceutical
Biotechnology. New Delhi: New Age International
Publishers; 1st edition 2006. p 25-27.
2. Punt J, Stanford S, Jones P, Owen A. Judith. Kuby
Immunology. United States: W.H Freeman & Company;
8th edition 2018. p 23-35.

More Related Content

What's hot (20)

Innate and adaptive immunity
Innate and adaptive immunityInnate and adaptive immunity
Innate and adaptive immunity
 
T-cell
T-cellT-cell
T-cell
 
Antigen & antigenicity
Antigen & antigenicityAntigen & antigenicity
Antigen & antigenicity
 
Immunodiffusion
Immunodiffusion Immunodiffusion
Immunodiffusion
 
Antigens
AntigensAntigens
Antigens
 
Antiboy- Structure and Function
Antiboy- Structure and FunctionAntiboy- Structure and Function
Antiboy- Structure and Function
 
Antigen processing and presentation
Antigen processing and presentationAntigen processing and presentation
Antigen processing and presentation
 
Cells & organs of immune system
Cells & organs of immune systemCells & organs of immune system
Cells & organs of immune system
 
Nature of antigens
Nature of antigensNature of antigens
Nature of antigens
 
Immunology (Innate and adaptive immune systems) (ANTIGENS (Ag))
Immunology (Innate and adaptive immune systems) (ANTIGENS (Ag)) Immunology (Innate and adaptive immune systems) (ANTIGENS (Ag))
Immunology (Innate and adaptive immune systems) (ANTIGENS (Ag))
 
Immunological techniques
Immunological techniquesImmunological techniques
Immunological techniques
 
Antigens ms
Antigens msAntigens ms
Antigens ms
 
Antibodies
AntibodiesAntibodies
Antibodies
 
Antigen
AntigenAntigen
Antigen
 
Brief history of immunology
Brief history of immunologyBrief history of immunology
Brief history of immunology
 
Antigen
AntigenAntigen
Antigen
 
Cell mediated & humoral immunity
Cell mediated & humoral immunityCell mediated & humoral immunity
Cell mediated & humoral immunity
 
T cellppt
T cellpptT cellppt
T cellppt
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
 
Mhc
MhcMhc
Mhc
 

Similar to Antigens & haptens

Immunogens and antigens
Immunogens and antigensImmunogens and antigens
Immunogens and antigensJyotipnigam
 
Multi Drug Resistence Bacteria.pptx
Multi Drug Resistence Bacteria.pptxMulti Drug Resistence Bacteria.pptx
Multi Drug Resistence Bacteria.pptxBIOGENLABS
 
L3.0 Antigen,Hapten and Immunogen.pptx
L3.0 Antigen,Hapten and Immunogen.pptxL3.0 Antigen,Hapten and Immunogen.pptx
L3.0 Antigen,Hapten and Immunogen.pptxVickshayo Sss
 
...Serological Technique Presentation Group 8 th.pptx
...Serological Technique Presentation Group 8 th.pptx...Serological Technique Presentation Group 8 th.pptx
...Serological Technique Presentation Group 8 th.pptxBIOGENLABS
 
Antigens and conepts of vaccine
Antigens and conepts of vaccineAntigens and conepts of vaccine
Antigens and conepts of vaccineshivaakumar
 
ANTIGEN & ANTIBODY AND THEIR REACTIONS
ANTIGEN & ANTIBODY AND THEIR REACTIONS ANTIGEN & ANTIBODY AND THEIR REACTIONS
ANTIGEN & ANTIBODY AND THEIR REACTIONS Gayathri Nair
 
Antigens and immunogens immunogenecity
Antigens and immunogens immunogenecityAntigens and immunogens immunogenecity
Antigens and immunogens immunogenecityHafiz M Waseem
 
Antigen lecture-51 (1)
Antigen lecture-51 (1)Antigen lecture-51 (1)
Antigen lecture-51 (1)Naeem Ahmed
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).pptnedalalazzwy
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).pptnedalalazzwy
 
Group no 6 immunology
Group no 6 immunologyGroup no 6 immunology
Group no 6 immunologyPeter Massawe
 
Antigen-Lecture-51 (1).ppt
Antigen-Lecture-51 (1).pptAntigen-Lecture-51 (1).ppt
Antigen-Lecture-51 (1).pptdipinbhandari
 

Similar to Antigens & haptens (20)

Immunogens and antigens
Immunogens and antigensImmunogens and antigens
Immunogens and antigens
 
Antigen.pptx
Antigen.pptxAntigen.pptx
Antigen.pptx
 
Multi Drug Resistence Bacteria.pptx
Multi Drug Resistence Bacteria.pptxMulti Drug Resistence Bacteria.pptx
Multi Drug Resistence Bacteria.pptx
 
Antigen.pptx
Antigen.pptxAntigen.pptx
Antigen.pptx
 
Hapten
HaptenHapten
Hapten
 
L3.0 Antigen,Hapten and Immunogen.pptx
L3.0 Antigen,Hapten and Immunogen.pptxL3.0 Antigen,Hapten and Immunogen.pptx
L3.0 Antigen,Hapten and Immunogen.pptx
 
...Serological Technique Presentation Group 8 th.pptx
...Serological Technique Presentation Group 8 th.pptx...Serological Technique Presentation Group 8 th.pptx
...Serological Technique Presentation Group 8 th.pptx
 
Antigens and conepts of vaccine
Antigens and conepts of vaccineAntigens and conepts of vaccine
Antigens and conepts of vaccine
 
Antigen.pptx
Antigen.pptxAntigen.pptx
Antigen.pptx
 
ANTIGEN & ANTIBODY AND THEIR REACTIONS
ANTIGEN & ANTIBODY AND THEIR REACTIONS ANTIGEN & ANTIBODY AND THEIR REACTIONS
ANTIGEN & ANTIBODY AND THEIR REACTIONS
 
antigen.pptx
antigen.pptxantigen.pptx
antigen.pptx
 
Antigens and immunogens immunogenecity
Antigens and immunogens immunogenecityAntigens and immunogens immunogenecity
Antigens and immunogens immunogenecity
 
Antigens notes
Antigens notes Antigens notes
Antigens notes
 
Antigen
AntigenAntigen
Antigen
 
Antigen lecture-51 (1)
Antigen lecture-51 (1)Antigen lecture-51 (1)
Antigen lecture-51 (1)
 
Antigen
Antigen Antigen
Antigen
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).ppt
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).ppt
 
Group no 6 immunology
Group no 6 immunologyGroup no 6 immunology
Group no 6 immunology
 
Antigen-Lecture-51 (1).ppt
Antigen-Lecture-51 (1).pptAntigen-Lecture-51 (1).ppt
Antigen-Lecture-51 (1).ppt
 

Recently uploaded

Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Scott Keck-Warren
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsMemoori
 
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...shyamraj55
 
Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...Alan Dix
 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Enterprise Knowledge
 
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024BookNet Canada
 
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphSIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphNeo4j
 
My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024The Digital Insurer
 
Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsMark Billinghurst
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):comworks
 
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024BookNet Canada
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupFlorian Wilhelm
 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machinePadma Pradeep
 
Benefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other FrameworksBenefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other FrameworksSoftradix Technologies
 
Artificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraArtificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraDeakin University
 
Unlocking the Potential of the Cloud for IBM Power Systems
Unlocking the Potential of the Cloud for IBM Power SystemsUnlocking the Potential of the Cloud for IBM Power Systems
Unlocking the Potential of the Cloud for IBM Power SystemsPrecisely
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 3652toLead Limited
 
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024BookNet Canada
 
Enhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for PartnersEnhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for PartnersThousandEyes
 

Recently uploaded (20)

Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial Buildings
 
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
 
Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...
 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024
 
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
 
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphSIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
 
My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024
 
Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR Systems
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):
 
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project Setup
 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machine
 
Benefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other FrameworksBenefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other Frameworks
 
Artificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraArtificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning era
 
Unlocking the Potential of the Cloud for IBM Power Systems
Unlocking the Potential of the Cloud for IBM Power SystemsUnlocking the Potential of the Cloud for IBM Power Systems
Unlocking the Potential of the Cloud for IBM Power Systems
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
 
Hot Sexy call girls in Panjabi Bagh 🔝 9953056974 🔝 Delhi escort Service
Hot Sexy call girls in Panjabi Bagh 🔝 9953056974 🔝 Delhi escort ServiceHot Sexy call girls in Panjabi Bagh 🔝 9953056974 🔝 Delhi escort Service
Hot Sexy call girls in Panjabi Bagh 🔝 9953056974 🔝 Delhi escort Service
 
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
 
Enhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for PartnersEnhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for Partners
 

Antigens & haptens

  • 1. Antigens & Haptens Name - Kajal Sharma Course – B. Pharm (8th sem) College – K.R. Mangalam University
  • 2. Antigens • Antigen is defined as ‘a macromolecular entity that essentially elicits an immune response via the formation of specific antibodies in the body of the host’. • They are the substances that are capable of inducing specific immune response. • They can be recognized by the surface antibody(B cells) or by the T cell receptors when associated with MHC (Major histocompatibility complex) molecule. • They can bind specifically with the antibody or T- cell receptor. MOST IMPORTANTLY All immunogen are antigen but all antigen are not immunogen (An immunogen is any antigen that is capable of inducing humoral and/or cell-mediated immune response)
  • 3. Classification of Antigens • EXOGENOUS ANTIGENS : Exogenous antigens are those antigens which enter into the host body from their surroundings or external environments. These are basically of pollutants, microorganisms, pollens, drugs etc. • ENDOGENOUS ANTIGENS : They are again classified onto- • Xenogenic or Heterogenic antigens • Allogenic or Idiotypic antigens • Autologous antigens.
  • 4. • XENOGENIC ANTIGENS : Foreign items which are related with tissue transplantation and serology. • ALLOGENIC ANTIGENS : Foreign items which enter when an individual receives a blood transfusion or undergoes transplantation operation. • AUTOLOGOUS ANTIGENS : This group of antigens is very rare and unnatural. In normal condition, self-components are non-immunogenic in nature, but in an abnormal condition self- body components are started to be considered as non-self or antigenic component.
  • 5. Immunogenicity v/s Antigenicity • IMMUNOGENICITY : Ability to induce a humoral or cell mediated immune response. • ANTIGENICITY : Ability to combine specifically with the final products of humoral or cell mediated immune response. • All molecules possessing the property of immunogenicity also possess the property of antigenicity. • Some molecules that possess the property of antigenicity but lack immunogenicity is known as haptens.
  • 6. Factors that influence Immunogenicity 1. Contribution of the Immunogen • Foreignness • Molecular size • Chemical Composition • Physical Form • Degradability 2. Contribution of the biological system • Genetic factors • Age 3. Method of administration • Dose • Route • Adjuvants
  • 7. Haptens • Haptens are low molecular weight compound or molecules. • Small organic molecules that are antigenic but not immunogenic. • They can bind to antibodies by themselves but they are not recognised by the immune cells. • And hence they fail to induce immune response, as a result no antibodies to act against hapten. • WHY HAPTENS ARE NOT IMMUNOGEN ? • Haptens cannot bind to MHC/MHC-II (Major histocompatibility complex). Hence cannot bind to TCR (T- cell receptor). • Results in no immune response
  • 8. • Haptens can be immunogenic if they are covalently coupled with a carrier protein. • The carrier protein must be a larger protein having a molecular weight of above 10,000 Da. • This hapten-carrier conjugate is recognized by immune cells and processed and presented to T-cell by MHC-II. • Hence antibodies are generated. When hapten carrier conjugate is introduced in body antibodies are generated against hapten, carrier protein or conjugate.
  • 9. Examples of Haptens • Urushiol from the plant poison ivy. • Hydralazine (generates autoimmune disease, Lupus erythematosus). • Nickel ion (ACD-allergic contact dermatitis). • Halothane (cause hepatitis). • Penicillin ( hemolytic anemia).
  • 10. Tests Test for Antigen : i. Direct ELISA ii. Direct Immunofluorescence iii. RIA ( Radioimmunoassay technique) iv. Neutralization test v. CFT (Complement fixation test) vi. Immunohistochemistry vii. rapid antigen test (RAT) Test for Hapten : i. Patch Test procedure
  • 11. References 1. Sambamurthy K, Kar Ashutosh. Pharmaceutical Biotechnology. New Delhi: New Age International Publishers; 1st edition 2006. p 25-27. 2. Punt J, Stanford S, Jones P, Owen A. Judith. Kuby Immunology. United States: W.H Freeman & Company; 8th edition 2018. p 23-35.

Editor's Notes

  1. MOST IMPORTANTLY All immunogen are antigen but all antigen are not immunogen